Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
Rimag is a Shenzhen-based medical imaging service provider.
RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.
Lomond Therapeutics creates pharmacological platforms that target escape mutations.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
OrbiMed has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 12 different industry categories.
Among tracked funding rounds, Verdiva Bio received $411.0M in a Series A round. OrbiMed's total known invested capital is $31.2B.
OrbiMed's average investment size is $108.2M across its portfolio of 288 companies.
Recent OrbiMed portfolio additions include Sirius Therapeutics, Fore Biotherapeutics, Rimag, RayThera, Lomond Therapeutics. These companies were founded in 2020 or later.